JP2018507850A5 - - Google Patents

Download PDF

Info

Publication number
JP2018507850A5
JP2018507850A5 JP2017541869A JP2017541869A JP2018507850A5 JP 2018507850 A5 JP2018507850 A5 JP 2018507850A5 JP 2017541869 A JP2017541869 A JP 2017541869A JP 2017541869 A JP2017541869 A JP 2017541869A JP 2018507850 A5 JP2018507850 A5 JP 2018507850A5
Authority
JP
Japan
Prior art keywords
vlt
transdermal therapeutic
adhesive transdermal
therapeutic system
patch
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017541869A
Other languages
English (en)
Japanese (ja)
Other versions
JP6785779B2 (ja
JP2018507850A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2016/052376 external-priority patent/WO2016124688A1/fr
Publication of JP2018507850A publication Critical patent/JP2018507850A/ja
Publication of JP2018507850A5 publication Critical patent/JP2018507850A5/ja
Application granted granted Critical
Publication of JP6785779B2 publication Critical patent/JP6785779B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017541869A 2015-02-04 2016-02-04 バレントニンを含む経皮治療システム並びにその医薬品としての使用 Expired - Fee Related JP6785779B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP15305161 2015-02-04
EP15305161.0 2015-02-04
PCT/EP2016/052376 WO2016124688A1 (fr) 2015-02-04 2016-02-04 Systeme therapeutique transdermique contenant de la valentonine et son utilisation comme medicament

Publications (3)

Publication Number Publication Date
JP2018507850A JP2018507850A (ja) 2018-03-22
JP2018507850A5 true JP2018507850A5 (https=) 2019-03-22
JP6785779B2 JP6785779B2 (ja) 2020-11-18

Family

ID=52573642

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017541869A Expired - Fee Related JP6785779B2 (ja) 2015-02-04 2016-02-04 バレントニンを含む経皮治療システム並びにその医薬品としての使用

Country Status (9)

Country Link
US (1) US10744122B2 (https=)
EP (1) EP3253378B1 (https=)
JP (1) JP6785779B2 (https=)
KR (1) KR102361801B1 (https=)
CN (1) CN107810003B (https=)
CA (1) CA2975985A1 (https=)
ES (1) ES2738633T3 (https=)
HU (1) HUE045679T2 (https=)
WO (1) WO2016124688A1 (https=)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2116036A1 (en) * 1991-10-18 1993-04-29 F. Eugene Yates Device for the transdermal administration of melatonin
DE4134493A1 (de) * 1991-10-18 1993-04-22 Teves Gmbh Alfred Blockiergeschuetzte hydraulische bremsanlage
FR2724384B1 (fr) 1994-09-14 1999-04-16 Cemaf Nouveaux derives de la 3,4-dihydro beta-carboline agonistes de la melatonine, leur procede de preparation et leur utilisation a titre de medicament
ATE443526T1 (de) * 1999-08-20 2009-10-15 Takeda Pharmaceutical Zusammensetzung für perkutane absorption mit einem melantoninrezeptor-agonistisch wirkendem wirkstoff
IL155666A (en) * 2003-04-29 2013-12-31 Neurim Pharma 1991 Insomnia treatment
FR2898358B1 (fr) 2006-03-08 2008-05-30 Macef Sa Association d'un antagoniste du recepteur 5ht2 et d'activateur du recepteur 5ht2 par modulation allosterique et leurs utilisations comme produits medicaux
FR2912405A1 (fr) * 2007-02-08 2008-08-15 Fourtillan Snc Derives des imidazo[1',5':1,6]pyrido[3,4-b]indoles et leur utilisation en therapeutique

Similar Documents

Publication Publication Date Title
CR20210368A (es) Combinación de dextrometorfano y bupropión para el tratamiento de depresión
MX2021004546A (es) Composiciones de suministro de farmaco implantables y metodos de uso de las mismas.
EA201500553A1 (ru) Многодневный пластырь для чрескожного введения ротиготина
WO2008049516A3 (de) Transdermales therapeutisches system enthaltend norelgestromin zur kontrazeption und hormonsubstitution
JP2017515869A5 (https=)
JP2017515872A5 (https=)
WO2008157103A3 (en) Modified release solid or semi-solid dosage forms
WO2011029948A3 (de) Transdermales therapeutisches system zur verabreichung von fentanyl oder einem analogstoff davon
WO2007028167A3 (en) Devices for transcutaneous delivery of vaccines and transdermal delivery of drugs and uses thereof
NZ605469A (en) Nalbuphine-based formulations and uses thereof
JP2013505282A5 (https=)
JP2017039781A5 (https=)
MY163809A (en) Transdermal drug delivery system containing donepezil
IN2014DN09817A (https=)
HK1215677A1 (zh) 经皮递送系统
WO2006084911A3 (en) Improved device for application of medicaments, manufacturing method therefor, and method of treatment
AR073435A1 (es) Composicion farmaceutica de liberacion modificada de un musculo relajante y un aine
WO2004056335A3 (es) Dispositivo de liberación que contiene venlafaxina y memantina
WO2016149077A3 (en) Fentanyl transdermal delivery system
JP2007119497A5 (https=)
MX2021012709A (es) Sistema terapeutico transdermico.
JP2019507786A5 (https=)
WO2014075203A1 (es) Nanopartículas con polímero biodegradable y biocompatible plga cargadas con el fármaco de uso humano pentoxfilina
JP2015516452A5 (https=)
WO2014111790A3 (en) Stable transdermal pharmaceutical drug delivery system comprising rivastigmine